Found: 76
Select item for more details and to access through your institution.
Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 3, p. N.PAG, doi. 10.1093/ofid/ofz076
- By:
- Publication type:
- Article
CMV drives clonal expansion of NKG2C<sup>+</sup> NK cells expressing self-specific KIRs in chronic hepatitis patients.
- Published in:
- European Journal of Immunology, 2012, v. 42, n. 2, p. 447, doi. 10.1002/eji.201141826
- By:
- Publication type:
- Article
Caroli's Disease: A Magnetic Resonance Cholangiopancreatography Diagnosis.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 1, p. 109, doi. 10.1111/j.1572-0241.1998.109_c.x
- By:
- Publication type:
- Article
Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir.
- Published in:
- Liver International, 2014, v. 34, p. 60, doi. 10.1111/liv.12424
- By:
- Publication type:
- Article
HCV direct-acting antiviral agents: the best interferon-free combinations.
- Published in:
- Liver International, 2014, v. 34, p. 69, doi. 10.1111/liv.12423
- By:
- Publication type:
- Article
Viral hepatitis: Impressive advances but still a long way to eradication of the disease.
- Published in:
- Liver International, 2014, v. 34, p. 1, doi. 10.1111/liv.12422
- By:
- Publication type:
- Article
HBsAg quantification: useful for monitoring natural history and treatment outcome.
- Published in:
- Liver International, 2014, v. 34, p. 97, doi. 10.1111/liv.12403
- By:
- Publication type:
- Article
Treatment of viral hepatitis: a new era.
- Published in:
- Liver International, 2013, v. 33, p. 1, doi. 10.1111/liv.12086
- By:
- Publication type:
- Article
The role of HBsAg quantification for monitoring natural history and treatment outcome.
- Published in:
- Liver International, 2013, v. 33, p. 125, doi. 10.1111/liv.12075
- By:
- Publication type:
- Article
Interferon free therapy with direct acting antivirals for HCV.
- Published in:
- Liver International, 2013, v. 33, p. 93, doi. 10.1111/liv.12076
- By:
- Publication type:
- Article
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
- Published in:
- Liver International, 2012, v. 32, n. 4, p. 612, doi. 10.1111/j.1478-3231.2011.02660.x
- By:
- Publication type:
- Article
Towards the eradication of hepatitis C virus.
- Published in:
- Liver International, 2012, p. 1, doi. 10.1111/j.1478-3231.2011.02726.x
- By:
- Publication type:
- Article
Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow.
- Published in:
- Liver International, 2012, p. 88, doi. 10.1111/j.1478-3231.2011.02699.x
- By:
- Publication type:
- Article
Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites.
- Published in:
- Liver International, 2011, v. 31, n. 4, p. 494, doi. 10.1111/j.1478-3231.2011.02448.x
- By:
- Publication type:
- Article
New direct-acting antivirals' combination for the treatment of chronic hepatitis C.
- Published in:
- Liver International, 2011, v. 31, p. 68, doi. 10.1111/j.1478-3231.2010.02411.x
- By:
- Publication type:
- Article
Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.
- Published in:
- Liver International, 2010, v. 30, n. 9, p. 1259, doi. 10.1111/j.1478-3231.2010.02283.x
- By:
- Publication type:
- Article
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.
- Published in:
- Liver International, 2009, v. 29, n. 4, p. 511, doi. 10.1111/j.1478-3231.2008.01918.x
- By:
- Publication type:
- Article
Protease and polymerase inhibitors for the treatment of hepatitis C.
- Published in:
- Liver International, 2009, v. 29, p. 57, doi. 10.1111/j.1478-3231.2008.01928.x
- By:
- Publication type:
- Article
Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 978, doi. 10.1111/apt.16807
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Editorial: HBV cure—the quest for biomarkers to predict off‐treatment sustained response.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 4, p. 552, doi. 10.1111/apt.16214
- By:
- Publication type:
- Article
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.
- Published in:
- Journal of Pathology, 2010, v. 221, n. 3, p. 264, doi. 10.1002/path.2703
- By:
- Publication type:
- Article
MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.
- Published in:
- Scientific Reports, 2016, p. 34935, doi. 10.1038/srep34935
- By:
- Publication type:
- Article
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144004
- By:
- Publication type:
- Article
IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0121395
- By:
- Publication type:
- Article
Abdominal pain in a 22 year old woman.
- Published in:
- Postgraduate Medical Journal, 2000, p. 583, doi. 10.1136/pmj.76.899.583
- By:
- Publication type:
- Article
Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 743, doi. 10.3390/cancers15030743
- By:
- Publication type:
- Article
COVID‐19‐associated hepatic artery pseudoaneurysms.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life.
- Published in:
- Liver International, 2021, v. 41, n. 7, p. 1509, doi. 10.1111/liv.14950
- By:
- Publication type:
- Article
New therapies for hepatitis delta virus infection.
- Published in:
- Liver International, 2021, v. 41, p. 30, doi. 10.1111/liv.14838
- By:
- Publication type:
- Article
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2385, doi. 10.1111/liv.14535
- By:
- Publication type:
- Article
Phase 3, Multicenter Open‐Label study to investigate the efficacy of elbasvir and grazoprevir fixed‐dose combination for 8 weeks in treatment‐naïve, HCV GT1b‐infected patients, with non‐severe fibrosis.
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 1853, doi. 10.1111/liv.14502
- By:
- Publication type:
- Article
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1042, doi. 10.1111/liv.14313
- By:
- Publication type:
- Article
Future treatments for hepatitis delta virus infection.
- Published in:
- Liver International, 2020, v. 40, p. 54, doi. 10.1111/liv.14356
- By:
- Publication type:
- Article
Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 778, doi. 10.1111/liv.14266
- By:
- Publication type:
- Article
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis.
- Published in:
- Liver International, 2018, v. 38, n. 9, p. 1583, doi. 10.1111/liv.13727
- By:
- Publication type:
- Article
Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?
- Published in:
- Liver International, 2018, v. 38, p. 7, doi. 10.1111/liv.13673
- By:
- Publication type:
- Article
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosis.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 443, doi. 10.1111/liv.13534
- By:
- Publication type:
- Article
Towards HBV curative therapies.
- Published in:
- Liver International, 2018, v. 38, p. 102, doi. 10.1111/liv.13656
- By:
- Publication type:
- Article
From HCV To HBV Cure.
- Published in:
- Liver International, 2017, v. 37, p. 73, doi. 10.1111/liv.13324
- By:
- Publication type:
- Article
Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives.
- Published in:
- Liver International, 2016, v. 36, p. 47, doi. 10.1111/liv.13027
- By:
- Publication type:
- Article
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
- Published in:
- Liver International, 2015, v. 35, n. 9, p. 2082, doi. 10.1111/liv.12787
- By:
- Publication type:
- Article
HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients.
- Published in:
- Liver International, 2015, v. 35, p. 82, doi. 10.1111/liv.12735
- By:
- Publication type:
- Article
Viral hepatitis: towards the eradication of HCV and a cure for HBV.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection.
- Published in:
- Liver International, 2015, v. 35, p. 56, doi. 10.1111/liv.12745
- By:
- Publication type:
- Article
Is screening baby boomers for HCV enough? A call to screen for hepatitis C virus in persons from countries of high endemicity.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230893
- By:
- Publication type:
- Article
Fibrosis evaluation in chronic hepatitis B: FIB-6 score.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients.
- Published in:
- Saudi Journal of Gastroenterology, 2019, v. 25, n. 5, p. 269, doi. 10.4103/sjg.SJG_445_19
- By:
- Publication type:
- Article
Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients.
- Published in:
- Saudi Journal of Gastroenterology, 2019, v. 25, n. 1, p. 55, doi. 10.4103/sjg.SJG_189_18
- By:
- Publication type:
- Article